Health Care & Life Sciences » Pharmaceuticals » Top pharmaceutical drugs | U.S. leading autoimmune disease products by sales 2016

Leading autoimmune disease products U.S. 2016, by sales

Leading autoimmune disease products in the United States in 2016, by sales (Figures expressed in billions of U.S. dollars, unless otherwise specified)

The data displays the best selling autoimmune disease products in the U.S. in 2016. Humira, manufactured by U.S. company AbbVie, was the top selling product of 2016 with 10.43 billion dollars in U.S. sales, far exceeding the second top seller Enbrel, manufactured by U.S. company Amgen.

Humira (AbbVie)	10.43
Enbrel (Amgen)	5.7
Remicade (Johnson & Johnson)	4.84
Stelara (Johnson & Johnson)	2.26
Simponi (Johnson & Johnson)	0.96
Entyvio (Takeda)	0.95
Cimzia (UCB)	0.93
Orencia (Bristol-Myers Squibb)	0.84
Xeljanz (Pfizer)	0.81
Otezla (Celgene)	0.78

Leading autoimmune disease products U.S. 2016, by sales

StatInvestor